NCT01316458View on ClinicalTrials.gov

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2010

Conditions
Prostatic NeoplasmGenital Neoplasms, MaleNeoplasms, AbdominalUrogenital NeoplasmsGenital Diseases, MaleProstatic DiseasesAntineoplastic AgentsImatinib
Interventions
DRUG

STI571 (Glivec®)

Trial Locations (13)

Unknown

Novartis Investigative Site, Aachen

Novarts Investigative Site, Berlin

Novartis Investigative Site, Bonn

Novartis Investigative Site, Borken

Novartis Investigative Site, Cologne

Novartis Investigative Site, Darmstadt

Novartis Investigative Site, Fürth

Novartis Investigative Site, Gardelegen

Novarts Investigative Site, Hamburg

Novartis Investigative Site, Marburg

Novartis Investigative Site, Ulm

Novartis Investigative Site, Wesel

Novartis Investigative Site, Wuppertal

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY